COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,158 Articles (22,703 medRxiv, 8,455 bioRxiv)

Most recent first Previous |  Page 1222: Articles 12211-12220  | Next

Alterations in CD39/CD73 Axis of T cells associated with COVID-19 severity
Dorneles, G. P., Teixeira, P. C., da Silva, I., Schipper, L. d. L., Santana Filho, P. C., Rodrigues Junior, L. C., Bonorino, C., Peres, A., Fonseca, S., Monteiro, M., Boeck, C., Eller, S., Oliveira, T. F., Wendland, E., Romao, P. R.
10.1101/2021.09.18.21263782 — Posted: 2021-09-22
Genomic analysis of SARS-CoV-2 breakthrough infections from Varanasi, India
Zaveri, L., Singh, R., Basu, P., Banu, S., Mukherjee, P., Vishwakarma, S., Sahni, C., Kaur, M., Singh, N. K., Yadav, A. K., Yadav, A. K., Ashish, A., Mishra, S., Tiwari, S., Mishra, S. P., Vodapalli, A., Bollu, H., Das, D., Singh, P. P., Chaubey, G., Sowpati, D. T., Tallapaka, K. B.
10.1101/2021.09.19.21262487 — Posted: 2021-09-22
COVID-19 Acceleration and Vaccine Status in France - August 2021
Baunez, C., Degoulet, M., Luchini, S., Pintus, P., Teschl, M.
10.1101/2021.09.18.21263773 — Posted: 2021-09-22
Cardiovascular Risk Factors and Outcomes in COVID-19: Hospital-Based Prospective Study in India
Sharma, A. K., Baig, V. N., Sharma, S., Dalela, G., Panwar, R. B., Katoch, V. M., Gupta, R.
10.1101/2021.09.19.21263788 — Posted: 2021-09-22
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge
Baden, L. R., ElSahly, H. M., Essink, B., Follman, D., Neuzil, K. M., August, A., Clouting, H., Fortier, G., Deng, W., Han, S., Zhao, X., Leav, B., Talarico, C., Girard, B., Paila, Y., Tomassini, J. E., Schodel, F., Pajon, R., Zhou, H., Das, R., Miller, J.
10.1101/2021.09.17.21263624 — Posted: 2021-09-22 Discussion: Onsite
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Lederer, K., Parvathaneni, K., Painter, M. M., Bettini, E., Agarwal, D., Lundgreen, K. A., Weirick, M., Goel, R. R., Xu, X., Drapeau, E. M., Gouma, S., Greenplate, A. R., Le Coz, C., Romberg, N., Jones, L., Rosen, M., Besharatian, B., Kaminiski, M., Weiskopf, D., Sette, A., Hensley, S. E., Bates, P., Wherry, E. J., Naji, A., Bhoj, V., Locci, M.
10.1101/2021.09.16.21263686 — Posted: 2021-09-21
Clinical Results with a B Cell Activating Anti-CD73 Antibody for the Immunotherapy of COVID-19
Miller, R. A., Guru, P., Bauer, P., Robles, J., Tomaszewski, C., Overcash, J. S., Waters, M., Cameron, M., Olalla Sierra, J., Janc, J., Rudnick, J. A., Hu, S., Jones, W. B., Kwei, L., Mahabhashyam, S., Willingham, S. B., Criner, G.
10.1101/2021.09.13.21263406 — Posted: 2021-09-21
Effectiveness of vaccination in preventing severe SARS CoV-2 infection in South India-a hospital based cross sectional study
ruban, A. c. p., Mohamed, A., Kalyanaraman, S.
10.1101/2021.09.17.21263670 — Posted: 2021-09-21
Prior Covid-19 and high RBD-IgG levels correlate with protection against VOC-delta SARS-CoV-2 infection in vaccinated Nursing Home Residents
Blain, H., TUAILLON, E., Pisoni, A., Soriteau, L., Million, E., Leglise, M.-S., Bussereau, I., Miot, S., Rolland, Y., Picot, M.-C., Bousquet, J. J.
10.1101/2021.09.21.21263880 — Posted: 2021-09-21
An epi-evolutionary model to predict spore-producing pathogens adaptation to quantitative resistance in heterogeneous environments
Fabre, F., Burie, J.-B., Ducrot, A., Lion, S., Richard, Q., Djidjou-Demasse, R.
10.1101/423467 — Posted: 2021-09-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).